Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 29;12(5):495.
doi: 10.3390/v12050495.

Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts

Affiliations
Review

Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts

Rayhane Nchioua et al. Viruses. .

Abstract

Restriction factors are structurally and functionally diverse cellular proteins that constitute a first line of defense against viral pathogens. Exceptions exist, but typically these proteins are upregulated by interferons (IFNs), target viral components, and are rapidly evolving due to the continuous virus-host arms race. Restriction factors may target HIV replication at essentially each step of the retroviral replication cycle, and the suppression of viral transcription and the degradation of viral RNA transcripts are emerging as major innate immune defense mechanisms. Recent data show that some antiviral factors, such as the tripartite motif-containing protein 22 (TRIM22) and the g-IFN-inducible protein 16 (IFI16), do not target HIV-1 itself but limit the availability of the cellular transcription factor specificity protein 1 (Sp1), which is critical for effective viral gene expression. In addition, several RNA-interacting cellular factors including RNAse L, the NEDD4-binding protein 1 (N4BP1), and the zinc finger antiviral protein (ZAP) have been identified as important immune effectors against HIV-1 that may be involved in the maintenance of the latent viral reservoirs, representing the major obstacle against viral elimination and cure. Here, we review recent findings on specific cellular antiviral factors targeting HIV-1 transcription or viral RNA transcripts and discuss their potential role in viral latency.

Keywords: HIV; N4BP1; RNAses; Sp1; ZAP/KHNYN; restriction factors; viral latency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Specificity protein 1 (Sp1) targeting suppresses HIV-1 transcription. As outlined in the text, the viral transactivator of transcription protein (Tat) interacts with the TAR region at the 5’ end of the viral RNA and recruits several cofactors for effective viral transcription. The latter is also dependent on the availability of the cellular transcription factors nuclear factor kappa B (NF-κB) and Sp1. Cellular factors tripartite motif-containing protein 22 (TRIM22) and γ-IFN-inducible protein 16 (IFI16) target Sp1 to suppress HIV-1 transcription and reactivation from latency.
Figure 2
Figure 2
Factors targeting HIV-1 RNA transcripts. Schematic presentation of cellular factors targeting viral RNAs to suppress translation of HIV-1 proteins and/or packaging of genomic viral RNAs.

References

    1. Gupta R.K., Abdul-Jawad S., McCoy L.E., Mok H.P., Peppa D., Salgado M., Martinez-Picado J., Nijhuis M., Wensing A.M., Lee H., et al. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation. Nature. 2019;568:244. doi: 10.1038/s41586-019-1027-4. - DOI - PMC - PubMed
    1. Hutter G., Nowak D., Mossner M., Ganepola S., Müßig A., Allers K., Schneider T., Hofmann J., Kücherer C., Blau O., et al. Long-Term Control of HIV by CCR5Δ32/Δ32 Stem-Cell Transplantation. N. Engl. J. Med. 2009;360:692–698. doi: 10.1056/NEJMoa0802905. - DOI - PubMed
    1. Ruelas D.S., Greene W.C. An integrated overview of HIV-1 latency. Cell. 2013;155:519–529. doi: 10.1016/j.cell.2013.09.044. - DOI - PMC - PubMed
    1. Siliciano R.F., Greene W.C. HIV Latency. [(accessed on 5 December 2018)];Cold Spring Harb. Perspect. Med. 2011 1:a007096. doi: 10.1101/cshperspect.a007096. Available online: http://www.ncbi.nlm.nih.gov/pubmed/22229121. - DOI - PMC - PubMed
    1. Darcis G., Van Driessche B., Van Lint C. HIV Latency: Should We Shock or Lock? Trends Immunol. 2017;38:217–228. doi: 10.1016/j.it.2016.12.003. - DOI - PubMed

Publication types

MeSH terms